Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort

The assessment of Ki-67 in early-stage breast cancer has become an important diagnostic tool in planning adjuvant therapy, particularly for the administration of additional chemotherapy to hormone-responsive patients. An accurate determination of the Ki-67 index is of the utmost importance; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Varga, Zsuzsanna, Li, Qiyu, Jochum, Wolfram, Perriard, Ulrike, Rau, Tilman, Tille, Jean-Christoph, Hawle, Hanne, Klingbiel, Dirk, Thuerlimann, Beat, Ruhstaller, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753092/
https://www.ncbi.nlm.nih.gov/pubmed/31537812
http://dx.doi.org/10.1038/s41598-019-49638-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753092/
https://www.ncbi.nlm.nih.gov/pubmed/31537812
http://dx.doi.org/10.1038/s41598-019-49638-4

Ejemplares similares